If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 1994.09-2002.08 Doctor of Philosophy, National Defense University, Taipei

Experience

  • 2018.03- Director, Department of Physiology, Taipei Medical University
  • 2017.08- Professor, Master Program fro Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
  • 2016.08- Director, Ph.D Program in Biotechnology Research and Development, Taipei Medical University
  • 2014.08- Graduate Institute of Clinical Medicine, Taipei Medical University
  • 2014.08- professor, Taipei Medical University Department of Physiology
  • 2011.08.01-2014.07 associated professor, Taipei Medical University Department of Physiology
  • 2010.02-2011.07 associated professor, Tzu Chi Unicersity
  • 2006.02-2010.02 assistant professor, Tzu Chi Unicersity
  • 2004.02-2005.07 assistant professor, Taipei Medical University
  • 2003.07-2004.02 postdoctor fellow, IBMS Academic Sinica
  • 2002.08-2003.07 Manger

URL

Research Interests

  • Renolpathology
  • molecular biology
  • Renal pathophysiology animal model

Fingerprint Dive into the research topics where Heng Lin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Peroxisome Proliferator-Activated Receptors Medicine & Life Sciences
Activating Transcription Factor 3 Medicine & Life Sciences
Kidney Medicine & Life Sciences
Endothelin-1 Medicine & Life Sciences
beraprost Medicine & Life Sciences
Apoptosis Medicine & Life Sciences
Epoprostenol Medicine & Life Sciences
Reperfusion Injury Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2011 2020

發展一新型藥物作為改善肥胖及肥胖引發糖尿病導致腎病變症候群之轉譯醫學研究(1/3)

Lin, H.

8/1/197/1/20

Project: A - Government Institutionb - Ministry of Science and Technology

發展新穎抗肥胖引發之代謝性疾病之單方藥做為未來轉譯醫學及相關應用

Lin, H.

8/1/187/31/19

Project: B - Project of TMUh - Other (Funded by TMU)

探討活化轉錄因子3調控microRNA 的分子機轉及臨床上的應用(3/3)

Lin, H.

8/1/169/30/17

Project: A - Government Institutionb - Ministry of Science and Technology

Evaluate the Molecluar Mechanims and Clinical Application on ATF3 Regulated microRNA

Lin, H.

8/1/157/31/16

Project: A - Government Institutionb - Ministry of Science and Technology

Research Output 1993 2019

  • 1499 Citations
  • 24 h-Index
  • 54 Article
  • 1 Review article
1 Citation (Scopus)

Homeostasis of glucose and lipid in non-alcoholic fatty liver disease

Chao, H. W., Chao, S. W., Lin, H., Ku, H. C. & Cheng, C. F., Jan 2 2019, In : International Journal of Molecular Sciences. 20, 2, 298.

Research output: Contribution to journalReview article

homeostasis
liver
glucose
Liver
Lipids

Progression of chronic kidney disease and the risk of tuberculosis: an observational cohort study

Cho, P. J-Y., Wu, C-Y., Johnston, J., Wu, M-Y., Shu, C-C. & Lin, H-H., May 1 2019, In : International Journal of Tuberculosis and Lung Disease. 23, 5, p. 555-562 8 p.

Research output: Contribution to journalArticle

Chronic Renal Insufficiency
Observational Studies
Tuberculosis
Cohort Studies
Glomerular Filtration Rate
1 Citation (Scopus)

SCUBE1-enhanced bone morphogenetic protein signaling protects against renal ischemia-reperfusion injury

Liao, W. J., Lin, H., Cheng, C. F., Ka, S. M., Chen, A. & Yang, R. B., Feb 1 2019, In : Biochimica et Biophysica Acta - Molecular Basis of Disease. 1865, 2, p. 329-338 10 p.

Research output: Contribution to journalArticle

Bone Morphogenetic Proteins
Reperfusion Injury
Kidney
Ischemia
Reperfusion
2 Citations (Scopus)

Multiplex detection of urinary miRNA biomarkers by transmission surface plasmon resonance

Yeung, W. K., Chen, H. Y., Sun, J. J., Hsieh, T. H., Mousavi, M. Z., Chen, H. H., Lee, K. L., Lin, H., Wei, P. K. & Cheng, J. Y., Oct 7 2018, In : Analyst. 143, 19, p. 4715-4722 8 p.

Research output: Contribution to journalArticle

Surface Plasmon Resonance
Surface plasmon resonance
Biosensing Techniques
Biomarkers
MicroRNAs
1 Citation (Scopus)

Role of activating transcription factor 3 in fructose-induced metabolic syndrome in mice

Chou, C. L., Li, C. H., Lin, H., Liao, M. H., Wu, C. C., Chen, J. S., Sue, Y. M. & Fang, T. C., Aug 1 2018, In : Hypertension Research. 41, 8, p. 589-597 9 p.

Research output: Contribution to journalArticle

Activating Transcription Factor 3
Fructose
Knockout Mice
Diet
Blood Pressure